Followers | 4 |
Posts | 427 |
Boards Moderated | 0 |
Alias Born | 02/07/2014 |
Friday, June 19, 2015 11:47:16 AM
Prana receives $6.8 million R&D Tax Incentive Refund
MELBOURNE, June 19th, 2015: Prana Biotechnology Limited (ASX:PBT/NASDAQ:PRAN) has today announced that it has received a $6.8 million cash refund under the Australian Government’s R&D Tax Incentive Scheme. The refund relates to the cost of eligible research
and development activities conducted during the 2014 financial year. These funds will be used to further Prana’s development of PBT2 for the treatment of Huntington’s Disease.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM